Children’s Hospital Archives
May. 1, 2023—A Vanderbilt study has identified four separate profiles to help medical professionals better assess children at elevated risk for a self-harm event.
Apr. 27, 2023—Kevin Churchwell, a former CEO of the Monroe Carell Jr. Children’s Hospital at Vanderbilt, recently spoke on the importance of equity, diversity and inclusivity for medical education in the hospital setting.
Apr. 13, 2023—A Vanderbilt study found that some children with mystery digestive symptoms may actually have undiagnosed alpha-gal syndrome, commonly known as the red meat allergy linked to tick bites.
Apr. 12, 2023—A new Vanderbilt poll finds that most Tennessee parents who own firearms agree with ways to safely store their firearms that have been shown through peer-reviewed research to reduce the risk of unintended harm to children.
Monroe Carell Jr. Children’s Hospital at Vanderbilt named among the 2023 “Best Hospitals for Pediatrics” by Money and The Leapfrog Group
Apr. 11, 2023—Monroe Carell Jr. Children’s Hospital at Vanderbilt is one of only 25 children’s hospitals to make Money/The Leapgfrog Group’s first-ever “Best Hospitals for Pediatrics” list and is the only pediatric hospital in Tennessee to earn the distinction.
Apr. 4, 2023—Vanderbilt research shows a common anesthesia drug could be beneficial in reducing pressure inside the skull of children with traumatic brain injuries.
Mar. 30, 2023—According to Tennessee’s 2022 Child Fatality Annual Report, over the past five years, white infants accounted for most of the sleep-related infant deaths in Tennessee, but Black infants were three times more likely to suffer a sleep-related fatality.
Mar. 30, 2023—Lily Hensiek's family has made a new $1 million commitment to endow the Lily’s Garden Discovery Researcher Fund in the Division of Pediatric Hematology and Oncology in the Department of Pediatrics at Vanderbilt University Medical Center.
Mar. 23, 2023—A Vanderbilt study of a treatment to delay the development of Type 1 diabetes in individuals at high risk did not meet the study goals of delaying progression from normal glucose tolerance to abnormal glucose tolerance or clinical diagnosis, although the study drug, abatacept, impacted immune response and preserved insulin production during the one-year treatment period.
Mar. 23, 2023—Vanderbilt University Medical Center has been named a fully accredited adult PCD (primary ciliary dyskinesia) Foundation Clinical and Research Center site.